Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Julphar
Deloitte
Express Scripts
Cipla
Baxter
Moodys
Chubb
Healthtrust

Generated: December 10, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Cetraxal

« Back to Dashboard

Bulk Pharmaceutical API Sources for Cetraxal

Vendor Vendor Homepage Vendor Sku API Url
ASINEX ➤ Sign Up BAS 06989041 ➤ Sign Up
Aronis ➤ Sign Up ARONIS020379 ➤ Sign Up
NovoSeek ➤ Sign Up 2764 ➤ Sign Up
Vitas-M Laboratory ➤ Sign Up STK021082 ➤ Sign Up
MP Biomedicals ➤ Sign Up 199020 ➤ Sign Up
MolPort ➤ Sign Up MolPort-000-819-654 ➤ Sign Up
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cerilliant
Colorcon
Accenture
Harvard Business School
Fuji
UBS
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.